DAS28-ESR may underestimate disease activity in rheumatoid arthritis patients with nonalcoholic fatty liver disease: a retrospective cohort study. [PDF]
Shinkawa Y +11 more
europepmc +1 more source
Medjool date seeds were dried, milled, and extracted (80°C, 180 min), followed by centrifugation (1000 rpm, 15 min) and BCA analysis to obtain the polysaccharide fraction (MDSP), which was characterized by TEM, FTIR, XPS, NMR, UV‐Vis, and TGA. In Balb/c mice with DSS‐induced colitis (2.25% DSS, Day 1.15), oral administration of MDSP‐H (300 mg/Kg ...
Sadeeq Ullah +10 more
wiley +1 more source
Down-regulation of AGXT2L1 promotes the development of nonalcoholic fatty liver disease. [PDF]
Yu Y, Wu L.
europepmc +1 more source
Nicotinamide mononucleotide (NMN) supplementation alleviated hepatic steatosis in mice with high‐fat diet‐induced non‐alcoholic fatty liver disease, improved serum lipid and fasting glucose profiles, and was associated with decreased hepatic PPAR‐γ expression and increased HNF4α and sex hormone‐binding globulin expression.
Yiwen Zhang +6 more
wiley +1 more source
Characterization of the gut virome in patients with nonalcoholic fatty liver disease. [PDF]
Wang L +10 more
europepmc +1 more source
Liquid Biopsy: Past, Present, and Future
Liquid biopsy has expanded from cancer genotyping to a broader strategy for probing both oncologic and nononcologic conditions through circulating analytes and multilayer molecular readouts. This review traces the field's past, present, and future—summarizing where liquid biopsy is most actionable today, why performance varies across contexts, and ...
Jiachen Liu +8 more
wiley +1 more source
Imaging mass cytometry reveals novel cellular neighborhoods for predicting the prognosis of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. [PDF]
Xu B +11 more
europepmc +1 more source
Suboptimal clinical response occurs in 20%–40% of patients after sleeve gastrectomy, yet reliable preoperative prediction remains challenging. We developed and externally validated an interpretable XGB model using multicenter data to identify patients at high risk of SCR.
Yuntao Nie +22 more
wiley +1 more source
Exploring the pathogenesis of nonalcoholic fatty liver disease complicated by atherosclerosis via bioinformatics. [PDF]
Yan R, Li P, Song J, Qiang Y, Zhai G.
europepmc +1 more source
Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets
ALD imposes a growing global burden influenced by alcohol consumption, genetic susceptibility, and obesity. Its pathogenesis involves interactions among ethanol metabolism, oxidative stress, innate immune activation, regulated cell death, and disruption of the gut–liver axis.
Shuyan Wang, Yirui Hu, Huikuan Chu
wiley +1 more source

